JomCare Study - A Harm Reduction Study
JomCare
Optimizing a Just-in-Time Adaptive Intervention to Increase Uptake of Chemsex Harm Reduction Services in MSM: A Micro-randomized Trial
2 other identifiers
interventional
482
1 country
1
Brief Summary
Chemsex, the use of psychoactive drugs before or during sexual activity, is a growing public health concern associated with striking increases in HIV, particularly among men who have sex with men (MSM). This study proposes to optimize an app-based just-in-time adaptive intervention, called JomCare, which aims to reduce chemsex risk by delivering tailored support when a person is most likely to be vulnerable to chemsex risk behaviors and receptive to intervention, with the purpose of reducing risk and averting new HIV infections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv
Started Apr 2026
Typical duration for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2025
CompletedFirst Posted
Study publicly available on registry
January 27, 2025
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 30, 2029
February 23, 2026
February 1, 2026
3.2 years
January 23, 2025
February 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants engaged in chemsex risk behavior
Use of chemsex-associated drugs, engagement in condomless anal sex, CAD overdose since the last EMA
Up to 6 months
Study Arms (5)
Information-based engagement prompts
EXPERIMENTALInformation-based engagement prompts are expected to improve participants' knowledge of harm reduction needs by providing information relevant to HIV (e.g., HIV/STI risk reduction), chemsex (e.g., safer drug use, CAD overdose prevention, drug interactions), and other topics (e.g., mental health).
Motivation-based engagement prompts
EXPERIMENTALMotivation-based engagement prompts are expected to increase the salience of participants' beliefs about the importance of their harm reduction needs.
Behavioral skills-based engagement prompts
EXPERIMENTALBehavioral skills-based engagement prompts are expected to improve self-efficacy and the ability to engage in intervention.
Generic engagement prompts
ACTIVE COMPARATORGeneric engagement prompts are included as active comparators to the theory-driven components, as they control for the potential influence of receiving any engagement prompts. Given the aim to optimize JITAI, including generic prompts provides the mechanism for distinguishing the effects of receiving any prompt from the theory-driven prompts.
No engagement prompt
NO INTERVENTIONNo engagement prompt is included as an inactive comparator. Participants will not receive any prompt when randomized to this group. Inclusion of the "no engagement prompt" will control for the potential impact of being notified of heightened risk, which could activate any pre-existing strategies to reduce or prevent risk.
Interventions
JomCare is a smartphone-based just-in-time adaptive intervention (JITAI) that uses an EMA-based machine learning (ML) algorithm to anticipate chemsex risk and deliver appropriate chemsex-related harm reduction and HIV prevention services when the risk is detected.
Eligibility Criteria
You may qualify if:
- Age ≥18 years;
- Cisgender man;
- HIV-negative or HIV status unknown;
- Having engaged in "chemsex" in the past 12 months (defined as using CAD, including crystal methamphetamine, mephedrone, GBL/GHB, and/or ecstasy/MDMA)
- Own a smartphone
You may not qualify if:
- Unable to provide informed consent
- Enrolled in drug rehabilitation, substance use treatment, and narcotics or other behavioral intervention-based treatment
- Unable to read and understand English or Bahasa Malaysia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute on Drug Abuse (NIDA)collaborator
- University of Texas at Tylercollaborator
- Ohio State Universitycollaborator
- University of Connecticutlead
- University of Malayacollaborator
- Yale Universitycollaborator
- University of Michigancollaborator
Study Sites (1)
University of Malaya
Kuala Lumpur, Malaysia
Related Publications (2)
Shrestha R, Lim SH, Altice FL, Copenhaver M, Wickersham JA, Saifi R, Ab Halim MA, Naning H, Kamarulzaman A. Use of Smartphone to Seek Sexual Health Information Online Among Malaysian Men Who Have Sex with Men (MSM): Implications for mHealth Intervention to Increase HIV Testing and Reduce HIV Risks. J Community Health. 2020 Feb;45(1):10-19. doi: 10.1007/s10900-019-00713-x.
PMID: 31375976RESULTRabbi M, Philyaw Kotov M, Cunningham R, Bonar EE, Nahum-Shani I, Klasnja P, Walton M, Murphy S. Toward Increasing Engagement in Substance Use Data Collection: Development of the Substance Abuse Research Assistant App and Protocol for a Microrandomized Trial Using Adolescents and Emerging Adults. JMIR Res Protoc. 2018 Jul 18;7(7):e166. doi: 10.2196/resprot.9850.
PMID: 30021714RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roman Shrestha, PhD
University of Connecticut
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 23, 2025
First Posted
January 27, 2025
Study Start
April 1, 2026
Primary Completion (Estimated)
May 30, 2029
Study Completion (Estimated)
May 30, 2029
Last Updated
February 23, 2026
Record last verified: 2026-02